C. Michaeloudes (London, United Kingdom), A. Szczepankiewicz (Poznan, Poland)
This session is built from abstracts published on the ERS Congress platform from 23 August, in an e-poster pdf format with a 3-minute audio narration. Participants and chairs of the session are invited to access all e-posters from 23 August to 4 September prior to the 1-hour live, online discussion scheduled from September 5-7. Please note that during live discussion there will be NO e-poster/abstract presentations, only discussion.
Mitigation of hippocampal cellular apoptosis and neuroinflammation after MV by diaphragm neurostimulation.
T. Bassi (Burnaby, Canada), E. Rohrs (Burnaby, Canada), K. Fernandez (Burnaby, Canada), M. Nicholas (Burnaby, Canada), M. Ornowska (Burnaby, Canada), M. Gani (Burnaby, Canada), D. Evans (Burnaby, Canada), S. Reynolds (Burnaby, Canada)
|   |
Rapamycin reduces eosinophilopoiesis through suppression of IL-5 production by bone marrow ILC2s
E. Boberg (Gothenburg, Sweden), J. Weidner (Gothenburg, Sweden), C. Malmhäll (Gothenburg, Sweden), J. Calvén (Gothenburg, Sweden), C. Corciulo (Gothenburg, Sweden), M. Rådinger (Gothenburg, Sweden)
| |
Short-range interactions between fibrocytes and CD8+ T cells modulate the balance between tissue repair and destruction in COPD
E. Eyraud (Bordeaux, France), E. Maurat (Bordeaux, France), P. Vallois (Nancy, France), F. Levet (Bordeaux, France), J. Sibareta (Bordeaux, France), P. Girodet (Bordeaux, France), M. Thumerel (Bordeaux, France), C. Contin-Bordes (Bordeaux, France), P. Berger (Bordeaux, France), I. Dupin (Bordeaux, France)
| |
Innate lymphocytes -ILC2- might be the drivers of T2-high nonatopic asthma in children
M. Bonato (Padova, Italy), E. Bazzan (Padova, Italy), D. Snijders (Padova, Italy), G. Turato (Padova, Italy), M. Turrin (Padova, Italy), M. Cosio (Montreal, Canada), A. Barbato (Padova, Italy), M. Saetta (Padova, Italy), S. Baraldo (Padova, Italy)
| |
Mast cell-derived serotonin enhances methacholine-induced airway hyperresponsiveness in house dust mite-induced experimental asthma
E. Mendez (Uppsala, Sweden), P. Alvarado Vazquez (Uppsala, Sweden), W. Abma (Stockholm, Sweden), O. Simonson (Uppsala , Sweden), S. Rodin (Heidelberg, Sweden), T. Feyerabend (Heidelberg, Germany), A. Malinovschi (Uppsala, Sweden), C. Janson (Uppsala, Sweden), M. Adner (Stockholm, Sweden), J. Hallgren (Uppsala, Sweden)
| |
Senescent human bronchial epithelial cells induce small airway fibrosis in mice
N. Saito (Barcelona, Spain), F. Hernandez (Barcelona, Spain), F. Pietrocola (Barcelona, Spain), M. Serrano (Barcelona, Spain)
| |
Mitochondrial DNA stress activates MHC class I antigen presentation and CD8+ T-cell immunity: implications for pulmonary fibrosis
X. Wang (Munich, Germany), T. Meul (Munich, Germany), I. Kammerl (Munich, Germany), Y. Wang (Munich, Germany), C. Mayr (Munich, Germany), H. Schiller (Munich, Germany), S. Meiners (Munich, Germany)
| |
Cytogenetic analysis in peripheral blood lymphocytes from asthmatic patients with different severity
A. Lintsov (St. Petersburg, Russian Federation), P. Slizhov (St. Petersburg, Russian Federation), A. Soliev (St. Petersburg, Russian Federation), S. Shevelev (St. Petersburg, Russian Federation), V. Mikhelson (St. Petersburg, Russian Federation)
| |
New possibilities for modifying the course of chronic obstructive pulmonary disease: the effect of tiotropium bromide on certain pathogenetic links of neocollagenogenesis of the bronchial tree
M. Ostrovskyy (Ivano-Frankivsk, Ukraine), M. Kulynych-Miskiv (Ivano-Frankivsk, Ukraine), K. Ostrovska (Ivano-Frankivsk, Ukraine), V. Miskiv (Ivano-Frankivsk, Ukraine), I. Savelikhina (Ivano-Frankivsk, Ukraine), O. Varunkiv (Ivano-Frankivsk, Ukraine), K. Shvets (Ivano-Frankivsk, Ukraine)
| |
The pIgR-IgA system as a new player in lung fibrosis
T. Planté-Bordeneuve (Brussels, Belgium), C. Pilette (Brussels, Belgium), Y. Yakoub (Brussels, Belgium), M. Lecocq (Brussels, Belgium), F. Huaux (Brussels, Belgium), A. Froidure (Brussels, Belgium)
| |
Genetic deletion of SLPI promotes inflammatory cell recruitment in a model of chronic lung disease
R. Brown (Belfast, United Kingdom), P. Ferris (Belfast, United Kingdom), C. Dougan (Belfast, United Kingdom), R. Delaney (Belfast, United Kingdom), D. Small (Belfast, United Kingdom), M. Mall (Berlin, Germany), S. Weldon (Belfast, United Kingdom), C. Taggart (Belfast, United Kingdom)
| |
Immunoproteasome function as a potential biomarker for asthma severity and response to therapy
L. Kaiser (Munich, Germany), S. Hardy (Munich, Germany), M. Frankenberger (Munich, Germany), K. Milger (Munich, Germany), S. Meiners (Munich, Germany)
| |
Exhausted T lymphocytes in chronic obstructive pulmonary disease: single-cell analysis of human lung tissue
S. Shin (Seoul, Republic of Korea), K. Kim (Suwon, Republic of Korea), K. Han (Seoul, Republic of Korea), J. Kim (Seoul, Republic of Korea), D. Park (Seoul, Republic of Korea), N. Kim (Seoul, Republic of Korea), C. Shon (Seoul, Republic of Korea), J. Huh (Seoul, Republic of Korea), S. Lee (Seoul, Republic of Korea), H. Park (Seoul, Republic of Korea)
| |
LSC - 2021 - Epidermal growth factor receptor in airway remodelling during allergic airway disease – divergent roles during early life and adulthood?
S. Helen, S. A. Walker (s.walker@imperial.ac.uk / National Heart and Lung Institute, I. College London,London), F. Puttur (f.puttur@imperial.ac.uk / National Heart and Lung Institute, I. College London,London), S. Saglani (s.saglani@imperial.ac.uk / National Heart and Lung Institute, I. College London,London), C. M. Lloyd (c.lloyd@imperial.ac.uk / National Heart and Lung Institute, I. College London,London)
| |
Functional state of erythrocytes in chronic obstructive pulmonary disease on the background of COVID-19, ways of correction
L. Todoriko (Chernivtsi, Ukraine), M. Gumeniuk (Kiyv, Ukraine), I. Semianiv (Chernivtsi, Ukraine), T. Sprynsian (Kiyv, Ukraine), ?. Denisov (Kiyv, Ukraine)
| |
The commensal bacterium Rothia mucilaginosa has anti-inflammatory properties in vitro and in vivo, and negatively correlates with sputum pro-inflammatory markers in chronic airway disease.
C. Rigauts (Ghent, Belgium), J. Aizawa (Anwerp, Belgium), S. Taylor (Adelaide, Australia), G. Rogers (Adelaide, Australia), M. Govaerts (Anwerp, Belgium), P. Cos (Anwerp, Belgium), L. Ostyn (Ghent, Belgium), S. Sims (Adelaide, Australia), E. Vandeplassche (Ghent, Belgium), M. Sze (Ghent, Belgium), Y. Dondelinger (Ghent, Belgium), L. Vereecke (Ghent, Belgium), H. Van Acker (Ghent, Belgium), J. Simpson (New South Wales, Australia), L. Burr (South Brisbane, Australia), A. Willems (GhentBrisbane, Belgium), M. Tunney (Belfast, Ireland), C. Cigana (Milan, Italy), A. Bragonzi (Milan, Italy), T. Coenye (Ghent, Belgium), A. Crabbé (Ghent, Belgium)
| |
Resistin, 8-isorpostanes and stress right ventricular diastolic dysfunction - predictors for exacerbations in non-severe chronic obstructive pulmonary disease patients
R. Cherneva (Sofia, Bulgaria), Z. Cherneva (Sofia, Bulgaria)
| |